BamSEC and AlphaSense Join Forces
Learn More

Seres Therapeutics Inc. – Material Contracts

NASDAQ: MCRB    
Share price (4/23/26): $8.09    
Market cap (4/23/26): $77.6 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.19
from 10-K 20 pages Amended and Restated Employment Agreement
12/34/56
EX-10.3
from 8-K 5 pages Seres Therapeutics, Inc. 101 Cambridge Park Drive Cambridge, Massachusetts 02140 March 2, 2026
12/34/56
EX-10.2
from 8-K 25 pages Seres Therapeutics, Inc. 101 Cambridge Park Drive Cambridge, Massachusetts 02140 March 2, 2026
12/34/56
EX-10.1
from 8-K 25 pages Seres Therapeutics, Inc. 101 Cambridge Park Drive Cambridge, Massachusetts 02140 March 2, 2026
12/34/56
EX-10.2
from 10-Q 4 pages October 1, 2025 Teresa Young Tyoung@serestherapeutics.com Re: Retention Bonus
12/34/56
EX-10.1
from 10-Q 4 pages October 1, 2025 Mathew Henn Mhenn@serestherapeutics.com Re: Retention Bonus
12/34/56
EX-10.3
from 10-Q 4 pages July 21, 2025 Thomas J. Desrosier by Email Re: Appointment as Co-CEO Dear Thomas
12/34/56
EX-10.2
from 10-Q 4 pages July 21, 2025 Marella Thorell by Email Re: Appointment as Co-CEO Dear Marella
12/34/56
EX-10.1
from 10-Q 3 pages July 21, 2025 Eric D. Shaff by Email Re: Transition Dear Eric
12/34/56
EX-10.2
from 10-Q 6 pages Seres Therapeutics, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.1
from 8-K 17 pages Seres Therapeutics, Inc. 2025 Incentive Award Plan
12/34/56
EX-10.7
from 10-Q 7 pages Mutual Termination of Collaboration and License Agreement
12/34/56
EX-10.6
from 10-Q 7 pages Mutual Termination of License Agreement
12/34/56
EX-10.4
from 8-K 13 pages Employee Support Agreement
12/34/56
EX-10.3
from 8-K 17 pages Cross-License Agreement
12/34/56
EX-10.2
from 8-K 94 pages Transition Services Agreement by and Between Seres Therapeutics, Inc., and Nestlé Enterprises S.A. Dated as of September 30, 2024
12/34/56
EX-10.1
from 8-K 16 pages Securities Purchase Agreement
12/34/56
EX-10.5
from 10-Q 9 pages Assignment and Termination of Manufacturing Agreement
12/34/56
EX-10.4
from 8-K 13 pages Form of Employee Support Agreement
12/34/56
EX-10.3
from 8-K 18 pages Form of Cross-License Agreement1
12/34/56